Clinical Outcome–Related Cancer Pathways and Mutational Signatures in Patients With Unresectable ESCC Receiving Chemoradiotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Clinical Outcome-Related Cancer Pathways and Mutational Signatures in Patients With Unresectable Esophageal Squamous Cell Carcinoma Treated With Chemoradiotherapy
Int. J. Radiat. Oncol. Biol. Phys 2022 Sep 24;[EPub Ahead of Print], L Li, J Sun, N Liu, R Yu, J Zhang, J Pang, Q Ou, Y Yin, J Cui, X Yao, R Zhao, Y Shao, S Yuan, J YuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.